Replies to post #9961 on Regen BioPharma Inc (RGBP)

[NEW4THIS]

Im not sure I agree that we are looking at 2 to 3 months. The fact that Hemxellerate does works very different from any current treatment is what has made it take longer (IMO), but also I believe that there is an immediate and great need for this to work due to the morbidity of this condition (and most patients are very young or very old). I believe that final steps have been taken or are on the table for Human clinical trials to begin. This also comes about by the new understanding of the mechanisms by which this is possible.

[DaveInMadisonWI]

Good post. Want to make sure we are on the same page though.

On 9/10 PR stated: 'The Company was informed that before it is cleared to initiate a clinical trial, it must submit additional safety data from experiments conducted in a GLP certified laboratory'.

On 1/14 PR stated: 'Currently FDA is reviewing protocols submitted by the Company for conducting an additional GLP safety study before clinical trials can begin'.

That 1/14 PR is almost 2 months old. I don't see any other company information regarding HemaXellerate since 1/14.

In those 2 months that have passed, do you think it's possible protocol has been approved and those GLP tests are underway as of today? My thought is the company wouldn't announce that they were, as although that may indicate progress to some, most investors would just view it as another fluff PR. Perhaps this is closer than one may think given some of the other events that have happened since the 1/14 PR.

I don't know either way, but I'm just thinking (or hoping) RGBP is closer than you infer. Thoughts?